Obesity-initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse model-Reference-Cited by-同舟云学术

Obesity-initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse model

Published:2016-04-04 Issue:11 Volume:76 Page:964-976
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

He Qiqi¹²,Babcook Melissa A.¹,Shukla Sanjeev¹,Shankar Eswar¹,Wang Zhiping²,Liu Guiming³,Erokwu Bernadette O.⁴,Flask Chris A.⁴⁵⁶,Lu Lan¹⁴,Daneshgari Firouz³,MacLennan Gregory T.⁷,Gupta Sanjay¹

Affiliation:

1. Department of Urology; Case Western Reserve University and University Hospitals Case Medical Center; Cleveland Ohio

2. Department of Urology; Key Laboratory of Disease of Urological Systems; Gansu Nephro-Urological Clinical Center; Second Hospital of Lanzhou University; Lanzhou Gansu China

3. Department of Surgery; MetroHealth Medical Center; Case Western Reserve University; Cleveland Ohio

4. Department of Radiology; Case Western Reserve University and University Hospitals Case Medical Center; Cleveland Ohio

5. Department of Biomedical Engineering; Case Western Reserve University; Cleveland Ohio

6. Department of Pediatrics; Case Western Reserve University and University Hospitals Case Medical Center; Cleveland Ohio

7. Department of Pathology; Case Western Reserve University and University Hospitals Case Medical Center; Cleveland Ohio

Funder

United States Public Health Services

China Scholarship Council

Publisher

Wiley

Subject

Urology,Oncology

Reference44 articles.

1. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity;Alberti;Circulation,2009

2. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins;Freedland;J Urol,2004

3. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia;Kasturi;Curr Prostate Rep,2006

4. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia;Ozden;Eur Urol,2007

5. Prevalence and incidence of endocrine and metabolic disorders in the United States: A comprehensive review;Golden;J Clin Endocrinol Metabol,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPER expression prevents estrogen-induced urinary retention in obese mice;The Journal of Steroid Biochemistry and Molecular Biology;2024-11

2. Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis;Journal of Neuroimmune Pharmacology;2024-07-23

3. Methylglyoxal and Advanced Glycation End Products (AGEs): Targets for the Prevention and Treatment of Diabetes-Associated Bladder Dysfunction?;Biomedicines;2024-04-23

4. The Ketone Bridge Between the Heart and the Bladder: How Fast Should We Go?;International Neurourology Journal;2024-02-29

5. How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI‐RS 2023: Part 1;Neurourology and Urodynamics;2024-01-04